0.00Open0.00Pre Close0 Volume0 Open Interest11.00Strike Price0.00Turnover0.00%IV55.03%PremiumAug 23, 2024Expiry Date0.00Intrinsic Value100Multiplier-1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma11.38Leverage Ratio--Theta--Rho--Eff Leverage--Vega
TG Therapeutics Stock Discussion
Larger Image: tradingview.com...
$TG Therapeutics (TGTX.US)$
Precision BioSciences Announces Investigational New Drug Clearance by Partner TG Therapeutics for Investigation of Azer-Cel for Multiple Sclerosis
$AGBA Group (AGBA.US)$
$TG Therapeutics (TGTX.US)$
No comment yet